Success Metrics

Clinical Success Rate
70.0%

Based on 7 completed trials

Completion Rate
70%(7/10)
Active Trials
2(14%)
Results Posted
29%(2 trials)
Terminated
3(21%)

Phase Distribution

Ph phase_1
3
21%
Ph phase_4
4
29%
Ph phase_2
2
14%
Ph not_applicable
5
36%

Phase Distribution

3

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
3(21.4%)
Phase 2Efficacy & side effects
2(14.3%)
Phase 4Post-market surveillance
4(28.6%)
N/ANon-phased studies
5(35.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.0%

7 of 10 finished

Non-Completion Rate

30.0%

3 ended early

Currently Active

2

trials recruiting

Total Trials

14

all time

Status Distribution
Active(2)
Completed(7)
Terminated(3)
Other(2)

Detailed Status

Completed7
Terminated3
unknown2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
14
Active
2
Success Rate
70.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (21.4%)
Phase 22 (14.3%)
Phase 44 (28.6%)
N/A5 (35.7%)

Trials by Status

completed750%
unknown214%
recruiting214%
terminated321%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14